{"id":"https://openalex.org/W4308396192","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.0849","title":"849 NT-I7, a novel long-acting interleukin-7, improves engraftment of patient immune cells and efficacy of anti-PD-1 therapy in a preclinical humanized melanoma model","display_name":"849 NT-I7, a novel long-acting interleukin-7, improves engraftment of patient immune cells and efficacy of anti-PD-1 therapy in a preclinical humanized melanoma model","publication_year":2022,"publication_date":"2022-11-01","ids":{"openalex":"https://openalex.org/W4308396192","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.0849"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2022-sitc2022.0849","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.0849","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2022-sitc2022.0849","pdf_url":"https://jitc.bmj.com/content/jitc/10/Suppl_2/A887.full.pdf","source":{"id":"https://openalex.org/S4363604233","display_name":"Regular and Young Investigator Award Abstracts","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://jitc.bmj.com/content/jitc/10/Suppl_2/A887.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091612468","display_name":"Yee Peng Phoon","orcid":"https://orcid.org/0000-0003-1660-3255","observed_orcids":["https://orcid.org/0000-0003-1660-3255"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yee Peng Phoon","raw_affiliation_strings":["Cleveland Clinic, Cleveland, OH, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland Clinic, Cleveland, OH, United States","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Kang Kai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kang Kai","raw_affiliation_strings":["Cleveland Clinic, Cleveland, OH, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland Clinic, Cleveland, OH, United States","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007640893","display_name":"Alexandra A. Wolfarth","orcid":"https://orcid.org/0000-0001-7902-8935","observed_orcids":["https://orcid.org/0000-0001-7902-8935"]},"institutions":[{"id":"https://openalex.org/I4405267539","display_name":"NeoImmuneTech, Inc. (United States)","ror":"https://ror.org/035t43f61","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267539"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexandra Wolfarth","raw_affiliation_strings":["NeoImmuneTech, Inc., Rockville, MD, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NeoImmuneTech, Inc., Rockville, MD, United States","institution_ids":["https://openalex.org/I4405267539"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016887010","display_name":"Sara Ferrando\u2010Mart\u00ednez","orcid":"https://orcid.org/0000-0003-0721-555X","observed_orcids":["https://orcid.org/0000-0003-0721-555X"]},"institutions":[{"id":"https://openalex.org/I4405267539","display_name":"NeoImmuneTech, Inc. (United States)","ror":"https://ror.org/035t43f61","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267539"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sara Ferrando-Martinez","raw_affiliation_strings":["NeoImmuneTech, Inc., Rockville, MD, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NeoImmuneTech, Inc., Rockville, MD, United States","institution_ids":["https://openalex.org/I4405267539"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004786915","display_name":"Byung Ha Lee","orcid":"https://orcid.org/0000-0002-4139-1226","observed_orcids":["https://orcid.org/0000-0002-4139-1226"]},"institutions":[{"id":"https://openalex.org/I4405267539","display_name":"NeoImmuneTech, Inc. (United States)","ror":"https://ror.org/035t43f61","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267539"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Byung Ha Lee","raw_affiliation_strings":["NeoImmuneTech, Inc., Rockville, MD, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NeoImmuneTech, Inc., Rockville, MD, United States","institution_ids":["https://openalex.org/I4405267539"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5087859996","display_name":"Brian Gastman","orcid":"https://orcid.org/0000-0003-2691-3409","observed_orcids":["https://orcid.org/0000-0003-2691-3409"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian Gastman","raw_affiliation_strings":["Cleveland Clinic, Cleveland, OH, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland Clinic, Cleveland, OH, United States","institution_ids":["https://openalex.org/I1316902750"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A887","last_page":"A887"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/interleukin-7","display_name":"IL-7","score":0.9649999737739563},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.7300000190734863},{"id":"https://openalex.org/keywords/humanized-mouse-model","display_name":"humanized mice","score":0.828000009059906},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.9670000076293945},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.8799999952316284},{"id":"https://openalex.org/keywords/cd4-t-cells","display_name":"CD4+ T cells","score":0.8640000224113464},{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.7250000238418579},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.6359999775886536},{"id":"https://openalex.org/keywords/tumor-growth","display_name":"tumor growth","score":0.4650000035762787}],"concepts":[{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.7660776972770691},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6901121735572815},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6202070116996765},{"id":"https://openalex.org/C2776156784","wikidata":"https://www.wikidata.org/wiki/Q3491954","display_name":"Humanized mouse","level":3,"score":0.5742684006690979},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5722928047180176},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.5428159236907959},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4403519928455353},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4290693402290344}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/jitc-2022-sitc2022.0849","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.0849","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2022-sitc2022.0849","pdf_url":"https://jitc.bmj.com/content/jitc/10/Suppl_2/A887.full.pdf","source":{"id":"https://openalex.org/S4363604233","display_name":"Regular and Young Investigator Award Abstracts","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2022-sitc2022.0849","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.0849","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2022-sitc2022.0849","pdf_url":"https://jitc.bmj.com/content/jitc/10/Suppl_2/A887.full.pdf","source":{"id":"https://openalex.org/S4363604233","display_name":"Regular and Young Investigator Award Abstracts","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4308396192.pdf","grobid_xml":"https://content.openalex.org/works/W4308396192.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4415699979","https://openalex.org/W4362543291","https://openalex.org/W4394759525","https://openalex.org/W7134916078","https://openalex.org/W4282929562","https://openalex.org/W4414325852","https://openalex.org/W2797031998","https://openalex.org/W7043830652","https://openalex.org/W2885502149","https://openalex.org/W3170154951"],"abstract_inverted_index":{"Background":[0],"Although":[1],"immune":[2,99,163,270,322],"checkpoint":[3],"inhibitors":[4],"(ICIs)":[5],"have":[6,347],"led":[7],"to":[8,20,39,44,77,126,144,180,209,259,268,301,312,351,357],"significant":[9],"massive":[10],"improvements":[11],"in":[12,84,107,195,232,316,400],"melanoma":[13,57,124,131,141,175,199,307],"survival,":[14],"half":[15],"of":[16,25,36,63,97,104,150,160,184,205,214,229,237,243,276,319,330,405],"these":[17],"patients":[18,125],"fail":[19],"benefit,":[21],"necessitating":[22],"the":[23,34,61,95,102,151,161,182,196,233,238,251,317,376,384,403,409,417],"discovery":[24],"novel":[26,314],"strategies.":[27],"There":[28],"is":[29],"a":[30,67,241,274,287,349,380],"pivotal":[31],"need":[32],"for":[33,60],"development":[35],"preclinical":[37,197],"models":[38],"evaluate":[40,313],"\u2018next-generation\u2019":[41],"immunotherapies":[42,315],"prior":[43,143],"clinical":[45,366],"investigation.":[46],"In":[47,262,344],"this":[48],"study,":[49],"we":[50,89,346],"developed":[51,348],"and":[52,82,87,101,116,155,168,235,284,323,336,406,413],"optimized":[53,173],"our":[54,108,128],"all-autologous":[55,305],"humanized":[56,109,130,198,306],"mouse":[58,110,132,200,308],"model":[59,152,176,309],"study":[62],"NT-I7":[64,73,91,185,191,206,217,225,248,266,283,326,335,354],"(efineptakin":[65],"alfa),":[66],"long-acting":[68],"recombinant":[69],"human":[70,371],"IL-7.":[71],"Because":[72],"has":[74],"been":[75],"shown":[76],"enhance":[78],"T":[79,244,277],"cell":[80,271],"proliferation":[81],"survival":[83],"both":[85,93],"humans":[86],"mice,":[88],"hypothesized":[90],"would":[92],"improve":[94],"engraftment":[96,159,228,329],"patient":[98,162,230,321,331],"cells":[100,115,164,245,278],"efficacy":[103,183],"anti-PD-1":[105,188,285,337],"therapy":[106],"model.":[111,133,201],"Methods":[112],"Both":[113],"tumor":[114,170,256,298,324,339],"peripheral":[117],"blood":[118],"lymphocytes":[119],"(PBLs)":[120],"were":[121,137,398],"collected":[122],"from":[123,393],"establish":[127],"autologous":[129,174],"Tumor-bearing":[134],"NSG":[135],"mice":[136],"infused":[138],"with":[139,187,240,254,264,273,388,402],"matched":[140,320],"PBLs":[142,231],"receiving":[145],"10":[146,215],"mg/kg":[147,216],"NT-I7.":[148],"Optimization":[149],"was":[153,177,192,207,341,373],"performed":[154,399],"evaluated":[156],"by":[157,383,408],"measuring":[158],"via":[165],"flow":[166],"cytometry":[167],"comparing":[169],"growth.":[171],"The":[172,202],"then":[178],"used":[179],"test":[181],"combined":[186],"therapy.":[189],"Results":[190],"well":[193],"tolerated":[194],"optimal":[203,359],"dosing":[204],"determined":[208],"be":[210,363],"two":[211],"subcutaneous":[212],"injections":[213],"1-2":[218],"weeks":[219],"apart":[220],"after":[221],"infusing":[222],"unexpanded":[223],"PBLs.":[224,332],"dramatically":[226,327],"increased":[227],"spleen":[234],"infiltration":[236],"tumor,":[239],"majority":[242,275],"being":[246,280],"CD4+.":[247,281],"also":[249],"enhanced":[250],"anti-tumor":[252,290],"response":[253],"decreased":[255,297],"growth":[257,299],"compared":[258,300],"vehicle":[260],"control.":[261,302],"combination":[263,294,355],"anti-PD-1,":[265],"continued":[267],"boost":[269],"engraftment,":[272],"still":[279],"While":[282],"displayed":[286],"similar":[288],"modest":[289],"effect":[291],"as":[292],"monotherapies,":[293],"treatment":[295],"significantly":[296,342],"Conclusions":[303],"Our":[304],"allows":[310],"us":[311],"context":[318],"cells.":[325],"improves":[328],"When":[333],"combining":[334],"therapy,":[338],"control":[340],"improved.":[343],"sum,":[345],"platform":[350],"feasibly":[352],"design":[353],"therapies":[356],"identify":[358],"strategies":[360],"that":[361],"can":[362],"translated":[364],"into":[365],"investigations.":[367],"Ethics":[368],"Approval":[369],"All":[370],"tissue":[372],"obtained":[374,392],"at":[375,416],"Cleveland":[377,418],"Clinic":[378],"under":[379],"protocol":[381],"approved":[382,407],"institutional":[385],"review":[386],"board":[387],"written":[389],"informed":[390],"consent":[391],"each":[394],"patient.":[395],"Animal":[396,411],"studies":[397],"accordance":[401],"guidelines":[404],"Institutional":[410],"Care":[412],"Use":[414],"Committee":[415],"Clinic.":[419]},"counts_by_year":[],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2022-11-11T00:00:00"}